Biopharmaceutical company MicuRx Pharmaceuticals has raised $55 million in Series C financing. GP Healthcare Capital led the round with participation from other investors that included GP TMT Capital, 3E Bioventures Capital and Delian Capital. In addition to the funding, Yu Miao of GP Healthcare Capital has been added to MicuRx’s board of directors.

Source: Press Release